Pliant Therapeutics (PLRX) Leases (2021 - 2025)
Pliant Therapeutics (PLRX) has disclosed Leases for 5 consecutive years, with $24.0 million as the latest value for Q4 2025.
- Quarterly Leases fell 12.03% to $24.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Dec 2025, down 12.03% year-over-year, with the annual reading at $24.0 million for FY2025, 12.03% down from the prior year.
- Leases for Q4 2025 was $24.0 million at Pliant Therapeutics, down from $24.8 million in the prior quarter.
- The five-year high for Leases was $28.1 million in Q3 2024, with the low at $1.2 million in Q4 2023.
- Average Leases over 5 years is $13.4 million, with a median of $6.1 million recorded in 2024.
- The sharpest move saw Leases crashed 77.67% in 2023, then surged 2149.63% in 2024.
- Over 5 years, Leases stood at $6.3 million in 2021, then fell by 14.34% to $5.4 million in 2022, then plummeted by 77.67% to $1.2 million in 2023, then soared by 2149.63% to $27.2 million in 2024, then fell by 12.03% to $24.0 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $24.0 million, $24.8 million, and $25.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.